These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32450102)

  • 1. Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort.
    Mather KJ; Bebu I; Baker C; Cohen RM; Crandall JP; DeSouza C; Green JB; Kirkman MS; Krause-Steinrauf H; Larkin M; Pettus J; Seaquist ER; Soliman EZ; Schroeder EB; Wexler DJ; Pop-Busui R;
    Diabetes Res Clin Pract; 2020 Jul; 165():108235. PubMed ID: 32450102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort.
    Gedebjerg A; Almdal TP; Berencsi K; Rungby J; Nielsen JS; Witte DR; Friborg S; Brandslund I; Vaag A; Beck-Nielsen H; Sørensen HT; Thomsen RW
    J Diabetes Complications; 2018 Jan; 32(1):34-40. PubMed ID: 29107454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence Of Diabetic Complications In Newly Diagnosed Type 2 Diabetes Patients In Pakistan: Findings From National Registry.
    Uddin F; Ali B; Junaid N
    J Ayub Med Coll Abbottabad; 2018; 30(Suppl 1)(4):S652-S658. PubMed ID: 30838825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes.
    An J; Nichols GA; Qian L; Munis MA; Harrison TN; Li Z; Wei R; Weiss T; Rajpathak S; Reynolds K
    BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33397671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular and macrovascular complications in type 2 diabetes Ghanaian residents in Ghana and Europe: The RODAM study.
    Hayfron-Benjamin C; van den Born BJ; Maitland-van der Zee AH; Amoah AGB; Meeks KAC; Klipstein-Grobusch K; Bahendeka S; Spranger J; Danquah I; Mockenhaupt F; Beune E; Smeeth L; Agyemang C
    J Diabetes Complications; 2019 Aug; 33(8):572-578. PubMed ID: 31167710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orthostatic hypotension in diabetic patients-10-year follow-up study.
    Gaspar L; Kruzliak P; Komornikova A; Celecova Z; Krahulec B; Balaz D; Sabaka P; Caprnda M; Kucera M; Rodrigo L; Uehara Y; Dukat A
    J Diabetes Complications; 2016; 30(1):67-71. PubMed ID: 26412028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
    Arnold SV; Khunti K; Tang F; Chen H; Cid-Ruzafa J; Cooper A; Fenici P; Gomes MB; Hammar N; Ji L; Saraiva GL; Medina J; Nicolucci A; Ramirez L; Rathmann W; Shestakova MV; Shimomura I; Surmont F; Vora J; Watada H; Kosiborod M
    Am Heart J; 2022 Jan; 243():232-239. PubMed ID: 34666013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dry eye and its correlation to diabetes microvascular complications in people with type 2 diabetes mellitus.
    Najafi L; Malek M; Valojerdi AE; Aghili R; Khamseh ME; Fallah AE; Tokhmehchi MR; Behrouz MJ
    J Diabetes Complications; 2013; 27(5):459-62. PubMed ID: 23726741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients.
    Moţăţăianu A; Maier S; Bajko Z; Voidazan S; Bălaşa R; Stoian A
    BMC Neurol; 2018 Aug; 18(1):126. PubMed ID: 30149797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of micro- and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort study.
    Arnold SV; Khunti K; Tang F; Chen H; Nicolucci A; Gomes MB; Ji L; Shestakova MV; Watada H; Cooper A; Fenici P; Hammar N; Medina J; Kosiborod M;
    Endocrinol Diabetes Metab; 2022 Mar; 5(2):e00321. PubMed ID: 35029066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin Resistance in Type 1 Diabetes Mellitus and Its Association with Patient's Micro- and Macrovascular Complications, Sex Hormones, and Other Clinical Data.
    Šimonienė D; Platūkiene A; Prakapienė E; Radzevičienė L; Veličkiene D
    Diabetes Ther; 2020 Jan; 11(1):161-174. PubMed ID: 31792784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular autonomic neuropathy is associated with macrovascular risk factors in type 2 diabetes: new technology used for routine large-scale screening adds new insight.
    Fleischer J; Yderstraede K; Gulichsen E; Jakobsen PE; Lervang HH; Eldrup E; Nygaard H; Tarnow L; Ejskjaer N
    J Diabetes Sci Technol; 2014 Jul; 8(4):874-80. PubMed ID: 24876410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline data.
    Gabriel R; Boukichou Abdelkader N; Acosta T; Gilis-Januszewska A; Gómez-Huelgas R; Makrilakis K; Kamenov Z; Paulweber B; Satman I; Djordjevic P; Alkandari A; Mitrakou A; Lalic N; Colagiuri S; Lindström J; Egido J; Natali A; Pastor JC; Teuschl Y; Lind M; Silva L; López-Ridaura R; Tuomilehto J;
    PLoS One; 2020; 15(4):e0231196. PubMed ID: 32282852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social Network Characteristics Are Associated With Type 2 Diabetes Complications: The Maastricht Study.
    Brinkhues S; Dukers-Muijrers NHTM; Hoebe CJPA; van der Kallen CJH; Koster A; Henry RMA; Stehouwer CDA; Savelkoul PHM; Schaper NC; Schram MT
    Diabetes Care; 2018 Aug; 41(8):1654-1662. PubMed ID: 29907582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
    Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J
    Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Chronic Diabetic Complications in Newly Diagnosed versus Known Type 2 Diabetic Subjects in a Sample of Alexandria Population, Egypt.
    Khalil SA; Megallaa MH; Rohoma KH; Guindy MA; Zaki A; Hassanein M; Malaty AH; Ismael HM; Kharboush IF; El Kafash DN; Sallam HN; Desouky IA
    Curr Diabetes Rev; 2019; 15(1):74-83. PubMed ID: 29366422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver fibrosis by FibroScan
    Lombardi R; Airaghi L; Targher G; Serviddio G; Maffi G; Mantovani A; Maffeis C; Colecchia A; Villani R; Rinaldi L; Orsi E; Pisano G; Adinolfi LE; Fargion S; Fracanzani AL
    Liver Int; 2020 Feb; 40(2):347-354. PubMed ID: 31612634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular and macrovascular complications of type 2 diabetic mellitus in Central, Kingdom of Saudi Arabia.
    Alaboud AF; Tourkmani AM; Alharbi TJ; Alobikan AH; Abdelhay O; Al Batal SM; Alkashan HI; Mohammed UY
    Saudi Med J; 2016 Dec; 37(12):1408-1411. PubMed ID: 27874160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.